- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Allison Brennan: Trump's Administration Is Encouraging Risk, but Possibly Too Quickly
By encouraging more providers to take on risk faster, the current administration may actually be disincentivizing providers from participating at all, which would reduce the number of accountable care organizations (ACOs), said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
By encouraging more providers to take on risk faster, the current administration may actually be disincentivizing providers from participating at all, which would reduce the number of accountable care organizations (ACOs), said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
Transcript
In what ways has the current administration encouraged or discouraged providers from taking on more risk?
The current administration is definitely encouraging providers to assume more accountability in the form of risk. We’ve seen this in a number of difference ways. There really is an emphasis to assume risk more quickly, and that’s something that I think we’re troubled by, but they view increased accountability as one of the main ways to reduce costs. I think we’re pushing back on that notion because we see a lot of really great work being done by our members to reduce costs and improve quality before they’re in a risk-based model.
One thing I would also note is that I think in a way the current administration has discouraged moving to risk by proposing to make the pipeline for ACOs, sort of, diminished. So, if we have fewer ACOs that are incentivized to enter the program, I think long term we’ll see fewer ACOs that are ready to take on risk.
So, it’s sort of a little bit of a catch 22: by pushing people into risk too fast, you may actually disincentivize them from participating at all.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
